Jump to content

Example Queries III: Difference between revisions

From CAMIH
Created page with "{{#ask: |Selenium||Curcumin |?has subobject.Outcome name |?has subobject.Outcome specification |headers=plain |limit=5 }}"
 
No edit summary
Line 1: Line 1:
== Überschrift ==
{{#ask:
{{#ask:
  [[has subobject.Reference.Topic::Cannabinoids||Selenium||Curcumin]]
  [[has subobject.Reference.Topic::Cannabinoids||Selenium||Curcumin]]
|?has subobject.Reference.Topic
  |?has subobject.Outcome name
  |?has subobject.Outcome name
  |?has subobject.Outcome specification
  |?has subobject.Outcome specification

Revision as of 16:02, 18 November 2024

Überschrift

 TopicOutcome nameOutcome specification
Asfour et al. (2006): Effect of high-dose sodium selenite therapy on polymorphonuclear leukocyte apoptosis in non-Hodgkin's lymphoma patientsSeleniumToxicity
Ejection fraction
Infectionrate after chemotherapy
Cardiac ejection fraction
Büntzel et al. (2010): Limited effects of selenium in the prevention of radiation-associated toxicities - results of a randomized study in head neck cancer patientsSeleniumToxicityGrade of radiotherapy-associated side effects: Xerostomia, stomatitis, ageusia, and dysphagia
Büntzel et al. (2010): Selenium Substitution During Radiotherapy of Solid Tumours - Laboratory Data from Two Observation Studies in Gynaecological and Head and Neck Cancer PatientsSeleniumSelenium levelSerum concentration and whole blood concentration
Côté et al. (2016): Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled TrialCannabinoidsPain
Weight
Appetite
Nausea
Unspecified effects
Toxicity
Quality of life
Pain with VAS + number of other analgesics used
Weight fluctuations, total days without feeding tube or gastrostomy
Appetite with questionnaire (no further information)
Nausea with questionnaire (no further information) + number of antiemetic drugs used
Sleep quality and mood (no information on survey)
Toxicity of nabilone
Quality of life (target improvement of 15 points at week 7)
Fallon et al. (2017) I: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studiesCannabinoidsPain
Pain
Pain
Pain
Pain
Quality of life
Median improvement in pain with NRS in %
Change in NRS value for average pain
Change in NRS value for the worst pain
Extent of sleep disturbance (assessed with NRS)
General intake, appropriate opioid intake for breakthrough pain and total opioid intake per day in morphine equivalents
Specification NRS: constipation NRS
... further results